| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q4 2021 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BAXTER INTL INC | 1 | Q4 2018 | 6.5% |
| ATHENEX INC | 1 | Q4 2018 | 6.2% |
| ZIMMER BIOMET HLDGS INC | 1 | Q4 2018 | 5.7% |
| ABBVIE INC | 1 | Q4 2018 | 5.3% |
| INCYTE CORP | 1 | Q4 2018 | 5.3% |
| QUANTERIX CORP | 1 | Q4 2018 | 4.7% |
| CELGENE CORP | 1 | Q4 2018 | 4.6% |
| AMGEN INC | 1 | Q4 2018 | 4.5% |
| MEDTRONIC PLC | 1 | Q4 2018 | 3.8% |
| QUOTIENT LTD | 1 | Q4 2018 | 3.7% |
View Diag Capital Management, LP's complete holdings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.